Lapinska-Szumczyk et al reported the significance of estrogen receptor (ER), progesterone receptor (PR) and HER2 markers in endometrial adenocarcinoma. The authors are from the Medical University of Gdansk in Poland.
Patient selection: endometrial adenocarcinoma
Parameters:
(1) ER and/or PR immunohistochemical staining
(2) HER2 immunohistochemical staining
ER and PR
HER2
5-Year Survival
10-Year Survival
one or both positive
negative
80%
75%
one or both positive
positive
70%
63%
both negative
negative
65%
60%
both negative
positive
40%
20%
To read more or access our algorithms and calculators, please log in or register.
